Landmark clinical evidence for intraoperative breast margin assessment in breast-conserving surgery

Published in JAMA Surgery, the BrIMA study demonstrates how high-resolution specimen PET-CT imaging can support more informed intraoperative margin management during breast-conserving surgery.

Download the study
Landmark clinical evidence for intraoperative breast margin assessment in breast-conserving surgery
Intraoperative success rate · Primary endpoint (IDC)
83.3% Without specimen PET-CT
95.2% With AURA 10® specimen PET-CT
Clinical challenge

Positive margins continue to challenge breast-conserving surgery

Despite advances in breast-conserving surgery, positive margins remain a common and clinically significant challenge. Conventional intraoperative assessment may not identify all positive margins, potentially resulting in additional surgery, increased patient burden, and higher healthcare costs.

In the BrIMA study, almost 1 in 4 patients had a positive margin after the initial breast tumor resection — in line with positive margin rates reported in the breast-conserving surgery literature.

Because definitive histopathology is not available during surgery, surgeons must often make margin-management decisions with incomplete information. The BrIMA study evaluated whether intraoperative specimen PET-CT imaging could improve identification of positive margins while the patient remained in the operating room.

1 in 4 ≈ 23%

patients had a positive margin after the initial tumor resection

AURA 10® PET-CT vs. conventional intraoperative assessment
AURA 10® PET-CT
Specimen stays in the OR
Surgeon-driven interpretation
3D whole-specimen imaging, no sampling bias
Molecular + structural (PET-CT) information
~10 minutes
Frozen sections
Specimen transported outside the OR
Requires a pathologist
2D information with sampling bias
20–50 minutes
Specimen X-ray
Specimen transported outside the OR
Requires a radiologist
2D images with superposition
About the BrIMA study

Prospective, multicenter clinical evidence

BrIMA is the largest prospective, multicenter clinical study evaluating high-resolution specimen PET-CT imaging for intraoperative breast margin assessment in breast-conserving surgery. Conducted across six European breast cancer centers, the study compared specimen PET-CT imaging with standard intraoperative assessment, using permanent histopathology as the reference standard.

Prospective clinical study
6
European breast cancer centers
148
Patients analyzed
Published in JAMA Surgery
Histopathology as reference standard
Know More.

Primary endpoint achieved

Intraoperative margin assessment success rates were numerically higher with AURA 10® PET-CT than with routine assessment alone.

95.2%
Intraoperative success rate

Intraoperative success rate with specimen PET-CT imaging in the IDC group.

> 1 in 6
Intraoperative management changed

PET-CT findings altered intraoperative management in more than 1 in 6 patients.

0.82
ICC

Good interobserver agreement.

PET-CT achieved the highest intraoperative success rate for addressing invasive positive margins during breast-conserving surgery.

Specimen PET-CT reached a 95.2% intraoperative success rate in the IDC group, compared with 83.3% for no intraoperative margin assessment (p < 0.001) and 86.9% for standard of care (p = 0.327).

By providing additional information during surgery, AURA 10 helps surgeons identify positive margins that might otherwise only be discovered after postoperative pathology review, allowing corrective action while the patient remains in the operating room.
Menekse Göker, MDPrincipal Investigator, BrIMA Study
Ghent University Hospital, Belgium
Clinical significance

What BrIMA means in clinical practice

1

Supports more informed intraoperative specimen evaluation.

2

Provides additional information before surgery is completed.

3

Integrates into existing breast-conserving surgery workflows with a 10-minute specimen scan.

See More.

Immediate specimen-level insight at the point of surgery

AURA 10® combines high-resolution PET and CT imaging to provide three-dimensional visualization of the surgical specimen during breast-conserving surgery.

Designed for use within the surgical workflow, AURA 10 provides additional intraoperative information while supporting intraoperative assessment and decision-making.

3D whole-specimen imaging
Combined PET + CT information
Spatial orientation back to the surgical cavity
~10-minute scan time
Surgeon-driven interpretation
Mobile OR-compatible platform
PACS + RIS connectivity
Specimen stays in the OR
Validated in a prospective multicenter clinical study
AURA 10 specimen PET-CT quad-view imaging
Explore the evidence

Read the complete JAMA Surgery publication and explore the clinical evidence supporting specimen PET-CT imaging during breast-conserving surgery.

Looking ahead

Advancing the evidence for intraoperative imaging

BrIMA represents an important milestone in the growing body of clinical evidence supporting specimen PET-CT imaging as an adjunct to conventional intraoperative assessment.

© 2026 XEOS. All rights reserved. Results reflect findings from the BrIMA clinical study. Refer to the full publication for complete methods, endpoints, and limitations.